Angene Chemical
Draw
|
Currency :
Home Products

AG003UH2

103628-48-4 | Sumatriptan Succinate

Chemical structure of Sumatriptan Succinate, CAS 103628-48-4
AG003UH2
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 103628-48-4
Catalog Number AG003UH2(AGN-PC-0OSI7D)
Chemical Name Sumatriptan Succinate
EC Number 600-463-4
IUPAC Name butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide
InChI InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
InChI Key PORMUFZNYQJOEI-UHFFFAOYSA-N
MDL Number MFCD00902856
Molecular Formula C18H27N3O6S
Molecular Weight 413.4885
NSC Number 760362
SMILES O=C(O)CCC(O)=O.O=S(CC1=CC2=C(NC=C2CCN(C)C)C=C1)(NC)=O
UNII J8BDZ68989
Synonyms
3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide, GR 43175, GR-43175, GR43175, Imigran, Succinate, Sumatriptan, Sumatriptan, Sumatriptan Succinate, SUMATRIPTAN SUCCINATE, 103628-48-4, Imigran, Imitrex, Suminat, mitrex, Migratriptan, Antibet, Arcoiran, Diletan, Imijekt, Micralgin, Migratan, Novelian, Permicran, Sumadol, Sumatrin, Sumigrene, Sumitrex, Migmax, Sumavel DosePro, 1-(3-(2-(Dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide succinate, Alsuma, Sumatriptan (succinate), Sumatriptan succinate [USAN], UNII-J8BDZ68989, GR 43175, GR 43175C, MFCD00902856, sumatriptan hydrogen succinate, CHEBI:64359, J8BDZ68989, GR-43175C, Onzetra Xsail, Zembrace SymTouch, Imitrex (TN), 3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide succinate (1:1), 1-{3-[2-(dimethylamino)ethyl]-1h-indol-5-yl}-n-methylmethanesulfonamide succinate, Q-201772, C18H27N3O6S, Zelrix, Imitrex Statdose, 1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-, butanedioate (1:1), 3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE-5-METHANESULFONAMIDE SUCCINATE, Butanedioic acid, compd. with 3-(2-(dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide (1:1), SMR000469158, Imigrane, Sumatriptan SDI, butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide, Zecutity (TN), C14H21N3O2S.C4H6O4, Sumatriptan-succinate, Alsuma (TN), Sumave dosepro (TN), AC1Q5VRF, succinic acid; sumatriptan, AC1L1RX2, SCHEMBL41674, MLS001401405, MLS006011969, Jsp000369, CHEMBL1201150, CTK8F0759, DTXSID60145966, TO-303S, PORMUFZNYQJOEI-UHFFFAOYSA-N, HMS2051H04, HMS2090G21, HMS2231K14, HMS3370G19, HMS3393H04, HMS3651E11, HMS3678A11, HMS3714G05, Pharmakon1600-01505372, Sumatriptan succinate (JAN/USAN), BCP05168, HY-B0121, AC-751, BG0326, GW 102, NSC760362, s1432, SN 308, SN-308, 3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl-N-methylmethanesulfonamide Succinate, AKOS015900409, AB07670, AN-1097, API0009779, CCG-100994, CS-1884, Imigran;mitrex;Imitrex;Suminat;Sumitrex, KS-1116, NC00244, NSC-760362, AK-56079, BC208270, CPD000469158, H689, LS-45735, SAM001246579, SC-19151, AB0013192, AB2000103, AX8017360, RT-015829, TL8000157, FT-0651836, S0851, ST24026862, SW197624-3, D00676, Sumatriptan succinate, >=98% (HPLC), solid, 628S484, A800771, SR-01000763688, I14-0769, SR-01000763688-4, F0001-2411, Z1551429732, 3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide succinate, Sumatriptan succinate, European Pharmacopoeia (EP) Reference Standard, Sumatriptan succinate, United States Pharmacopeia (USP) Reference Standard, 1-[3-(2-DIMETHYLAMINOETHYL)-1H-INDOL-5-YL]-N-METHYL-METHANESULFONAMIDE SUCCINATE, 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide; succinic acid, 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide butanedioate, 1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide; butanedioic acid, 3-[2-(DiMethylaMino)ethyl]-N-Methyl-1H-indole-5-MethanesulfonaMide,butanedioate, 3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide,butanedioate(1:1), butanedioic acid; 1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide, butanedioic acid; 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide, butanedioic acid; 1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide, N,N-dimethyl-2-{5-[(methylsulfamoyl)methyl]-1H-indol-3-yl}ethanaminium 3-carboxypropanoate, Sumatriptan for system suitability, European Pharmacopoeia (EP) Reference Standard, CID59772, 103628-48-4 (succinate), CS-O-08219, GR-43175, A5294, C14-H21-N3-O2-S.C4-H6-O4, 103628-46-2, Sumatriptan succinate, 98%, a 5-HT1 receptor agonist - 100MG 100mg, (3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide succinic acid, 1-(3-(2-dimethylaminoethyl)-1h-indol-5-yl)-n-methyl-methanesulfonamide succinate, Butanedioic acid, compd. with 3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide (1:1),

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited